Results 161 to 170 of about 878,839 (299)

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

WDFY4-dependent cross-presentation proceeds via a vacuolar antigen-processing route. [PDF]

Proc Natl Acad Sci U S A
Postoak JL, Koch A, Shan S, Ohara RA, Jo S, Chen J, Desai P, Ou F, Kraft M, Diamond MS, Kim S, Murphy TL, Murphy KM.   +12 more
europepmc   +1 more source

Performance Characteristics of Anti–Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick, Marcela A. Ferrada, Alice Fike, Kaitlin A. Quinn, Benjamin A. Turturice, Casey Stein, Peter C Grayson   +6 more
wiley   +1 more source

The Role of the Autoimmune Regulator Gene in the Control of MHC II Antigen-Processing and Presentation by Medullary Thymic Epithelial Cells. [PDF]

HLA
Monteleone-Cassiano AC, Pinto RD, Ferreirinha P, Cipriano UG, Gembre AF, Bonato VLD, Passos GA, Alves NL, Donadi EA.   +8 more
europepmc   +1 more source

Maintenance of Hypoimmunogenic Features via Regulation of Endogenous Antigen Processing and Presentation Machinery. [PDF]

Front Bioeng Biotechnol, 2022
An JH, Koh H, Ahn Y, Kim J, Han AR, Lee JY, Kim SU, Lee JH.   +7 more
europepmc   +1 more source

Computer-aided techniques for Chromogenic Immunohistochemistry: Status and Directions [PDF]

, 2012
Al-Kofahi, Al-Kofahi, Baggett, Beck, Bogen, Borad, Boykov, Brennan, Brey, Brgmann, Canny, Cheng, Choudhury, Cooper, Cregger, Cross, Cualing, De Solorzano, Demir, Di Cataldo, Di Cataldo, Diaz, Dickinson, DiVito, Dobson, Elisa Ficarra, Elmoataz, Enrico Macii, Ficarra, Ficarra, Ficarra, Flowers, Fuchs, Garrido, Gilbert, Goldstein, Gudla, Gurcan, Gustavson, Hai-Shan Wu, Hama, Han, Hanna, He, Huang, Ingle, Jacob, Kim, Kong, Kurosumi, Lacroix-Triki, Landini, Lehr, Leong, Loos, Luck, Madabhushi, Makretsov, Malpica, Marttila, Masmoudi, Mccullough, Moffitt, Moon, Mueller, Mukherjee, Otsu, Petushi, Pietrini, Queschi, Ramos-Vara, Riera, Roerdink, Rojo, Ruifrok, Santa Di Cataldo, Scholzen, Sharpe, Shi, Shi, Slodkowska, Sompuram, Sun, Taneja, Taylor, Taylor, Theodosiou, Thiran, Tuominen, Umemura, Vonesch, Wang, Ward, Wolff, Woolley, Yang, Zacharaki, Zanella   +97 more
core   +1 more source

Diagnostic Use of Testing for Novel Murine Autoantibodies for Sjögren Disease in the Rheumatology Outpatient Setting

Arthritis Care &Research, EarlyView.
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr, Michael D. George, Vatinee Y. Bunya, Nora Sandorfi, Mina Massaro‐Giordano, Frederick B. Vivino   +5 more
wiley   +1 more source

Optimal murine CD4⁺ T cell priming by mRNA-lipid nanoparticle vaccines requires endogenous antigen processing. [PDF]

Nat Commun
Rood JE, Yoon SK, Heard MK, Carro SD, Hedgepeth EJ, O'Mara ME, Hogan MJ, Le N, Muramatsu H, Lam K, Schreiner P, Kasden C, Stedman HH, Langlois RA, Heyes J, Pardi N, Eisenlohr LC.   +16 more
europepmc   +1 more source

Combining Three Peripheral Blood Biomarkers to Stratify Rheumatoid Arthritis–Associated Interstitial Lung Disease Risk

Arthritis Care &Research, EarlyView.
Objective The purpose was to evaluate a biomarker score consisting of MUC5B rs35705950 promoter variant, plasma matrix metalloproteinase‐7 (MMP‐7), and serum anti–malondialdehyde‐acetaldehyde (anti‐MAA) antibody for rheumatoid arthritis (RA)–associated interstitial lung disease (ILD) risk stratification.
Kelsey Coziahr, Austin M. Wheeler, Brent A. Luedders, Michael Duryee, Halie Frideres, Katherine D. Wysham, Grant W. Cannon, Gary Kunkel, Dana P. Ascherman, Paul A. Monach, Gail S. Kerr, Andreas M. Reimold, Scott M. Matson, Joshua F. Baker, Geoffrey M. Thiele, Ted R. Mikuls, Bryant R. England   +16 more
wiley   +1 more source

Imaging antigen processing and presentation in cancer. [PDF]

Immunother Adv
Lau D, Elliott T.
europepmc   +1 more source